FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageuz.dhp.integrations
Resource TypeConceptMap
IdConceptMap-dhis-observation-component-to-loinc.json
FHIR VersionR5
Sourcehttps://build.fhir.org/ig/uzinfocom-org/digital-health-integration/ConceptMap-dhis-observation-component-to-loinc.html
URLhttps://terminology.dhp.uz/fhir/integrations/ConceptMap/dhis-observation-component-to-loinc
Version0.1.0
Statusdraft
Date2026-07-20T13:54:46+00:00
NameObservationComponentToLoinc
TitleTuberculosis Drug Susceptibility Components to LOINC
DescriptionMaps the local DHIS drug-susceptibility-test component codes to their LOINC [Susceptibility] code. Where the relationship is `equivalent` (plain drug-name agents), use the LOINC code directly in resources (see the DHIS Observation Component Code ValueSet); concentration-bearing agents are narrower and keep their local code. Non-drug component codes (interpretations, grading, identification flags) have no LOINC equivalent and are not listed.

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
kl.dk.fhir.children#2.1.0loinc.orgLogical Observation Identifiers, Names and Codes (LOINC)
uz.dhp.integrations#currentdhis-observation-component-code-csDHIS Observation Component Code CodeSystem

Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: ConceptMap dhis-observation-component-to-loinc

Mapping from (not specified) to All LOINC codes


Mapping from DHIS Observation Component Code CodeSystemversion: 0.1.0) to http://loinc.org (Logical Observation Identifier Names and Codes (LOINC))

Source CodeRelationshipTarget Code
tub004-0007 (Rifampitsin (1,0 mg/ml))is narrower than18974-6 (Rifampin [Susceptibility])
tub004-0008 (Izoniazid (0,1 mg/ml))is narrower than18934-0 (Isoniazid [Susceptibility])
tub004-0009 (Etambutol (5,0 mg/ml))is narrower than18921-7 (Ethambutol [Susceptibility])
tub004-0010 (Pirazinamid (100 mg/ml))is narrower than18973-8 (Pyrazinamide [Susceptibility])
tub004-0011 (Levofloksatsin (2,0 mg/ml))is narrower than20629-2 (Levofloxacin [Susceptibility])
tub004-0012 (Moksifloksatsin (1,0 mg/ml))is narrower than31039-1 (Moxifloxacin [Susceptibility])
tub004-0013 (Moksifloksatsin (0,25 mg/ml))is narrower than31039-1 (Moxifloxacin [Susceptibility])
tub004-0014 (Gatifloksatsin (0,25 mg/ml))is narrower than31038-3 (Gatifloxacin [Susceptibility])
tub004-0015 (Amikatsin (1,0 mg/ml))is narrower than18860-7 (Amikacin [Susceptibility])
tub004-0016 (Protionamid (2,5 mg/ml))is narrower than100057-9 (Prothionamide [Susceptibility])
tub004-0017 (Linezolid (1,0 mg/ml))is narrower than29258-1 (Linezolid [Susceptibility])
tub004-0018 (Klofazimin (1,0 mg/ml))is narrower than23627-3 (Clofazimine [Susceptibility])
tub004-0019 (Bedaquilin (1,0 mg/ml))is narrower than94274-8 (Bedaquiline [Susceptibility])
tub004-0020 (Delamanid (0,06 mg/ml))is narrower than93851-4 (Delamanid [Susceptibility])
tub004-0021 (Pretomanid (1,0 mg/ml))is narrower than93850-6 (Pretomanid [Susceptibility])
tub004-0025 (Ethionamide-Prothionamide)is related to18922-5 (Ethionamide [Susceptibility])
tub004-0022 (Rifampcin)is equivalent to18974-6 (Rifampin [Susceptibility])
tub004-0028 (Levofloxacin)is equivalent to20629-2 (Levofloxacin [Susceptibility])
tub004-0029 (Amikacin)is equivalent to18860-7 (Amikacin [Susceptibility])
tub004-0030 (Kanamycin)is equivalent to18935-7 (Kanamycin [Susceptibility])

Russian


Сгенерированный нарратив: ConceptMap dhis-observation-component-to-loinc

Сопоставление с (не указано) до All LOINC codes


Сопоставление с DHIS Observation Component Code CodeSystemверсия: 0.1.0) to http://loinc.org (Logical Observation Identifier Names and Codes (LOINC))

Исходный кодОтношенияЦелевой код
tub004-0007 (Rifampitsin (1,0 mg/ml))is narrower than18974-6 (Rifampin [Susceptibility])
tub004-0008 (Izoniazid (0,1 mg/ml))is narrower than18934-0 (Isoniazid [Susceptibility])
tub004-0009 (Etambutol (5,0 mg/ml))is narrower than18921-7 (Ethambutol [Susceptibility])
tub004-0010 (Pirazinamid (100 mg/ml))is narrower than18973-8 (Pyrazinamide [Susceptibility])
tub004-0011 (Levofloksatsin (2,0 mg/ml))is narrower than20629-2 (Levofloxacin [Susceptibility])
tub004-0012 (Moksifloksatsin (1,0 mg/ml))is narrower than31039-1 (Moxifloxacin [Susceptibility])
tub004-0013 (Moksifloksatsin (0,25 mg/ml))is narrower than31039-1 (Moxifloxacin [Susceptibility])
tub004-0014 (Gatifloksatsin (0,25 mg/ml))is narrower than31038-3 (Gatifloxacin [Susceptibility])
tub004-0015 (Amikatsin (1,0 mg/ml))is narrower than18860-7 (Amikacin [Susceptibility])
tub004-0016 (Protionamid (2,5 mg/ml))is narrower than100057-9 (Prothionamide [Susceptibility])
tub004-0017 (Linezolid (1,0 mg/ml))is narrower than29258-1 (Linezolid [Susceptibility])
tub004-0018 (Klofazimin (1,0 mg/ml))is narrower than23627-3 (Clofazimine [Susceptibility])
tub004-0019 (Bedaquilin (1,0 mg/ml))is narrower than94274-8 (Bedaquiline [Susceptibility])
tub004-0020 (Delamanid (0,06 mg/ml))is narrower than93851-4 (Delamanid [Susceptibility])
tub004-0021 (Pretomanid (1,0 mg/ml))is narrower than93850-6 (Pretomanid [Susceptibility])
tub004-0025 (Ethionamide-Prothionamide)is related to18922-5 (Ethionamide [Susceptibility])
tub004-0022 (Rifampcin)is equivalent to18974-6 (Rifampin [Susceptibility])
tub004-0028 (Levofloxacin)is equivalent to20629-2 (Levofloxacin [Susceptibility])
tub004-0029 (Amikacin)is equivalent to18860-7 (Amikacin [Susceptibility])
tub004-0030 (Kanamycin)is equivalent to18935-7 (Kanamycin [Susceptibility])

Uzbek


Generated Narrative: ConceptMap dhis-observation-component-to-loinc

Mapping from (not specified) to All LOINC codes


Mapping from DHIS Observation Component Code CodeSystemversion: 0.1.0) to http://loinc.org (Logical Observation Identifier Names and Codes (LOINC))

Source CodeRelationshipTarget Code
tub004-0007 (Rifampitsin (1,0 mg/ml))is narrower than18974-6 (Rifampin [Susceptibility])
tub004-0008 (Izoniazid (0,1 mg/ml))is narrower than18934-0 (Isoniazid [Susceptibility])
tub004-0009 (Etambutol (5,0 mg/ml))is narrower than18921-7 (Ethambutol [Susceptibility])
tub004-0010 (Pirazinamid (100 mg/ml))is narrower than18973-8 (Pyrazinamide [Susceptibility])
tub004-0011 (Levofloksatsin (2,0 mg/ml))is narrower than20629-2 (Levofloxacin [Susceptibility])
tub004-0012 (Moksifloksatsin (1,0 mg/ml))is narrower than31039-1 (Moxifloxacin [Susceptibility])
tub004-0013 (Moksifloksatsin (0,25 mg/ml))is narrower than31039-1 (Moxifloxacin [Susceptibility])
tub004-0014 (Gatifloksatsin (0,25 mg/ml))is narrower than31038-3 (Gatifloxacin [Susceptibility])
tub004-0015 (Amikatsin (1,0 mg/ml))is narrower than18860-7 (Amikacin [Susceptibility])
tub004-0016 (Protionamid (2,5 mg/ml))is narrower than100057-9 (Prothionamide [Susceptibility])
tub004-0017 (Linezolid (1,0 mg/ml))is narrower than29258-1 (Linezolid [Susceptibility])
tub004-0018 (Klofazimin (1,0 mg/ml))is narrower than23627-3 (Clofazimine [Susceptibility])
tub004-0019 (Bedaquilin (1,0 mg/ml))is narrower than94274-8 (Bedaquiline [Susceptibility])
tub004-0020 (Delamanid (0,06 mg/ml))is narrower than93851-4 (Delamanid [Susceptibility])
tub004-0021 (Pretomanid (1,0 mg/ml))is narrower than93850-6 (Pretomanid [Susceptibility])
tub004-0025 (Ethionamide-Prothionamide)is related to18922-5 (Ethionamide [Susceptibility])
tub004-0022 (Rifampcin)is equivalent to18974-6 (Rifampin [Susceptibility])
tub004-0028 (Levofloxacin)is equivalent to20629-2 (Levofloxacin [Susceptibility])
tub004-0029 (Amikacin)is equivalent to18860-7 (Amikacin [Susceptibility])
tub004-0030 (Kanamycin)is equivalent to18935-7 (Kanamycin [Susceptibility])

Source1

{
  "resourceType": "ConceptMap",
  "id": "dhis-observation-component-to-loinc",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://terminology.dhp.uz/fhir/integrations/ConceptMap/dhis-observation-component-to-loinc",
  "version": "0.1.0",
  "name": "ObservationComponentToLoinc",
  "title": "Tuberculosis Drug Susceptibility Components to LOINC",
  "status": "draft",
  "experimental": false,
  "date": "2026-07-20T13:54:46+00:00",
  "publisher": "Uzinfocom LLC",
  "contact": [
    {
      "name": "Uzinfocom LLC",
      "telecom": [
        {
          "system": "url",
          "value": "https://uzinfocom.uz"
        },
        {
          "system": "email",
          "value": "info@uzinfocom.uz"
        }
      ]
    }
  ],
  "description": "Maps the local DHIS drug-susceptibility-test component codes to their LOINC [Susceptibility] code. Where the relationship is `equivalent` (plain drug-name agents), use the LOINC code directly in resources (see the DHIS Observation Component Code ValueSet); concentration-bearing agents are narrower and keep their local code. Non-drug component codes (interpretations, grading, identification flags) have no LOINC equivalent and are not listed.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "UZ",
          "display": "Uzbekistan"
        }
      ]
    }
  ],
  "targetScopeCanonical": "http://loinc.org/vs",
  "group": [
    {
      "source": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs|0.1.0",
      "target": "http://loinc.org",
      "element": [
        {
          "code": "tub004-0007",
          "display": "Rifampitsin (1,0 mg/ml)",
          "target": [
            {
              "code": "18974-6",
              "display": "Rifampin [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0008",
          "display": "Izoniazid (0,1 mg/ml)",
          "target": [
            {
              "code": "18934-0",
              "display": "Isoniazid [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0009",
          "display": "Etambutol (5,0 mg/ml)",
          "target": [
            {
              "code": "18921-7",
              "display": "Ethambutol [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0010",
          "display": "Pirazinamid (100 mg/ml)",
          "target": [
            {
              "code": "18973-8",
              "display": "Pyrazinamide [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0011",
          "display": "Levofloksatsin (2,0 mg/ml)",
          "target": [
            {
              "code": "20629-2",
              "display": "Levofloxacin [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0012",
          "display": "Moksifloksatsin (1,0 mg/ml)",
          "target": [
            {
              "code": "31039-1",
              "display": "Moxifloxacin [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0013",
          "display": "Moksifloksatsin (0,25 mg/ml)",
          "target": [
            {
              "code": "31039-1",
              "display": "Moxifloxacin [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0014",
          "display": "Gatifloksatsin (0,25 mg/ml)",
          "target": [
            {
              "code": "31038-3",
              "display": "Gatifloxacin [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0015",
          "display": "Amikatsin (1,0 mg/ml)",
          "target": [
            {
              "code": "18860-7",
              "display": "Amikacin [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0016",
          "display": "Protionamid (2,5 mg/ml)",
          "target": [
            {
              "code": "100057-9",
              "display": "Prothionamide [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0017",
          "display": "Linezolid (1,0 mg/ml)",
          "target": [
            {
              "code": "29258-1",
              "display": "Linezolid [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0018",
          "display": "Klofazimin (1,0 mg/ml)",
          "target": [
            {
              "code": "23627-3",
              "display": "Clofazimine [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0019",
          "display": "Bedaquilin (1,0 mg/ml)",
          "target": [
            {
              "code": "94274-8",
              "display": "Bedaquiline [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0020",
          "display": "Delamanid (0,06 mg/ml)",
          "target": [
            {
              "code": "93851-4",
              "display": "Delamanid [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0021",
          "display": "Pretomanid (1,0 mg/ml)",
          "target": [
            {
              "code": "93850-6",
              "display": "Pretomanid [Susceptibility]",
              "relationship": "source-is-narrower-than-target"
            }
          ]
        },
        {
          "code": "tub004-0025",
          "display": "Ethionamide-Prothionamide",
          "target": [
            {
              "code": "18922-5",
              "display": "Ethionamide [Susceptibility]",
              "relationship": "related-to"
            }
          ]
        },
        {
          "code": "tub004-0022",
          "display": "Rifampcin",
          "target": [
            {
              "code": "18974-6",
              "display": "Rifampin [Susceptibility]",
              "relationship": "equivalent"
            }
          ]
        },
        {
          "code": "tub004-0028",
          "display": "Levofloxacin",
          "target": [
            {
              "code": "20629-2",
              "display": "Levofloxacin [Susceptibility]",
              "relationship": "equivalent"
            }
          ]
        },
        {
          "code": "tub004-0029",
          "display": "Amikacin",
          "target": [
            {
              "code": "18860-7",
              "display": "Amikacin [Susceptibility]",
              "relationship": "equivalent"
            }
          ]
        },
        {
          "code": "tub004-0030",
          "display": "Kanamycin",
          "target": [
            {
              "code": "18935-7",
              "display": "Kanamycin [Susceptibility]",
              "relationship": "equivalent"
            }
          ]
        }
      ]
    }
  ]
}